Since the discovery of elevated levels of nitrosamines in certain pharmaceuticals, reported in July 2018, finding the right solutions have become a major focus for many pharmaceutical manufacturers, particularly as they are considered probable human carcinogens.
Download this guide to learn more about:
- Requirements for nitrosamine analysis
- Why is nitrosamine analysis in drugs important?
- Cost effective nitrosamine screening with MS/MS